Gerwin Heller

17PUBLICATIONS
50CO-AUTHORS
Cancer cell biologyMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Peripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 18, 2025
CDK6 kinase inhibition unmasks metabolic dependencies in BCR::ABL1+ leukemia.

Lisa Scheiblecker, Thorsten Klampfl, Eszter Doma

|Apr 10, 2023
Frequent Overexpression of HER3 in Brain Metastases from Breast and Lung Cancer.

Erwin Tomasich, Ariane Steindl, Christina Paiato

|Dec 11, 2022
Pharmacological Inhibition of Lipid Import and Transport Proteins in Ovarian Cancer.

Lisa Lemberger, Renate Wagner, Gerwin Heller

|Aug 23, 2022
Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns.

Maximilian J Mair, Annette Leibetseder, Gerwin Heller

|Mar 26, 2022
DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma.

Angelika Martina Starzer, Gerwin Heller, Erwin Tomasich

|Mar 25, 2022
CDK6 Degradation Is Counteracted by p16<sup>INK4A</sup> and p18<sup>INK4C</sup> in AML.

Belinda S Schmalzbauer, Teresemary Thondanpallil, Gerwin Heller

Pageof 3

Frequent Collaborators

5 joint publications

Rotraud Wieser

5 joint publications

Anna Sophie Berghoff

3 joint publications

Hubert Hackl

3 joint publications

Alexander Michael Grandits